Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP).

التفاصيل البيبلوغرافية
العنوان: Computational fluid dynamic modeling of the effect of dupilumab in the management of anosmia secondary to chronic rhinosinusitis with nasal polyps (CRSwNP).
المؤلفون: Lepley TJ; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Wu Z; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Root Z; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Mountain D; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Otto BA; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Kelly K; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA., Zhao K; Department of Otolaryngology-Head & Neck Surgery, The Ohio State University, Columbus, Ohio, USA.
المصدر: International forum of allergy & rhinology [Int Forum Allergy Rhinol] 2022 Dec; Vol. 12 (12), pp. 1578-1580. Date of Electronic Publication: 2022 Jul 11.
نوع المنشور: Letter; Research Support, N.I.H., Extramural
اللغة: English
بيانات الدورية: Publisher: Published for ARS-AAOA by Wiley-Blackwell Country of Publication: United States NLM ID: 101550261 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2042-6984 (Electronic) Linking ISSN: 20426976 NLM ISO Abbreviation: Int Forum Allergy Rhinol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: Hoboken : Published for ARS-AAOA by Wiley-Blackwell
مواضيع طبية MeSH: Nasal Polyps*/drug therapy , Nasal Polyps*/complications , Sinusitis*/complications , Sinusitis*/drug therapy , Rhinitis*/complications , Rhinitis*/drug therapy, Humans ; Anosmia ; Hydrodynamics ; Chronic Disease
References: Drug Des Devel Ther. 2020 May 08;14:1757-1769. (PMID: 32440101)
J Allergy Clin Immunol Pract. 2022 Apr;10(4):1086-1095.e5. (PMID: 34628065)
J Clin Med. 2022 May 10;11(10):. (PMID: 35628815)
Lancet. 2019 Nov 2;394(10209):1638-1650. (PMID: 31543428)
J Biomech. 2017 Nov 7;64:59-68. (PMID: 28893392)
Expert Opin Biol Ther. 2021 May;21(5):575-585. (PMID: 33724109)
معلومات مُعتمدة: R01 DC013626 United States DC NIDCD NIH HHS; R21 DC017530 United States DC NIDCD NIH HHS
المشرفين على المادة: 420K487FSG (dupilumab)
تواريخ الأحداث: Date Created: 20220629 Date Completed: 20221201 Latest Revision: 20240521
رمز التحديث: 20240521
مُعرف محوري في PubMed: PMC10162444
DOI: 10.1002/alr.23050
PMID: 35765860
قاعدة البيانات: MEDLINE
الوصف
تدمد:2042-6984
DOI:10.1002/alr.23050